WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals announces the launch of INVELTYS and the hiring of a specialty ophthalmology sales organization.
Category: Business
NovaBay Pharmaceuticals Announces Preliminary 2018 Net Sales and Introduces 2019 Net Sales Guidance
EMERYVILLE, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Dryeye?src=hash" target="_blank"gt;#Dryeyelt;/agt;–NovaBay Pharmaceuticals Announces Preliminary 2018 Net Sales and Introduces 2019 Net Sales Guidance
Aerie Pharmaceuticals Announces Positive Topline Results of Netarsudil Ophthalmic Solution in Pilot Phase 2 Study Supporting Clinical Development in Japan
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Katalyst Surgical Files FTC Complaint Urging Investigation into Iridex Corporation for Anticompetitive Business Practices
CHESTERFIELD, Mo.–(BUSINESS WIRE)–Katalyst Surgical Files FTC Complaint Urging Investigation into Iridex Corporation for Anticompetitive Business Practices
Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
NEW YORK–(BUSINESS WIRE)–Ophthotech announced that Glenn P. Sblendorio, CEO and President, will present an overview of the Company at the J.P. Morgan Healthcare Conference.
Western Dental Completes Acquisition of EyeMax Vision Plan and is Set to Begin Offering Vision Coverage to Groups and Individuals in California
ORANGE, Calif.–(BUSINESS WIRE)–Premier Dental Holdings, Inc., parent of Western Dental Services, has completed the purchase of EyeMax Vision Plan, a Knox-Keene licensed specialized health care service plan for vision. EyeMax recently completed the bu…
OcuSciences Announces Publication Showing Flavoprotein Fluorescence May Detect Improvement in Metabolic Function Preceding Structural Improvement in Patients with Diabetic Macular Edema Treated with Anti-VEGF
ANN ARBOR, Mich.–(BUSINESS WIRE)–OcuSciences, Inc., a clinical-stage biotechnology company developing retinal imagers to detect early disease by assessing retinal metabolic activity, today announced the online publication of its diabetic macular edem…
Kedalion Therapeutics to Present at Biotech Showcase 2019
MENLO PARK, Calif.–(BUSINESS WIRE)–Kedalion Therapeutics, Inc., a clinical-stage company focused on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream™ platform, today announced that Pete…
Ophthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of Directors
NEW YORK–(BUSINESS WIRE)–Ophthotech announced the election of Calvin (Cal) W. Roberts, M.D., to Its Board of Directors, effective as of January 1.
Ocular Therapeutix™ Announces Completion of Debt Refinancing
BEDFORD, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target="_blank"gt;#OCUTXlt…
Eye Health America Celebrates Record-Breaking First Year
ATLANTA–(BUSINESS WIRE)–Eye Health America (EHA), a leader in eye care practice management, announced today its 2018 end-of-year recap, which included seven acquisitions of ophthalmology and optometry practices and ambulatory surgery centers across t…
2019 New Year’s Resolution: Give Your Eyes a Rest
CHATTANOOGA, Tenn.–(BUSINESS WIRE)–Employee benefits company Unum found nearly 40% of U.S. adults spend 12+ hours a day on devices, triggering symptoms of digital eye strain.
The Global Market for Ophthalmic Lasers (2018-2023) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Laser Market – Forecasts From 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering. The Ophthalmic Laser market is projected to grow at a CAGR of 6.09% to reach US$706.588 million by 2023, from US$495.529 million in 2017. Growing prevalence of ophthalmic diseases like glaucoma, cataract and other vision related issues and increasing initiatives by the government to control visual impairment are expected to drive the growth of the mark
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
Satralizumab von Chugai erhält von FDA den Status „Breakthrough Therapy“ für Neuromyelitis optica und Neuromyelitis-optica-Spektrum-Erkrankungen
TOKIO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) gab bekannt, dass die US-amerikanische Zulassungsbehörde FDA den Status „Breakthrough Therapy“ (Durchbruchtherapie) für Chugais humanisierten, rezyklierenden An…
Physicians’ Education Resource® Presents the 16th Annual Winter Lung Cancer Conference™
CRANBURY, N.J.–(BUSINESS WIRE)–Physicians’ Education Resource® Presents the 16th Annual Winter Lung Cancer Conference™
Ophthalmics – Global Partnering Report (2012-2018): Updated Deal Trends, Players and Financials – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmics Partnering 2012-2018: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Ophthalmics Partnering 2012 to 2018 provides the full collection of Ophthalmics disease deals signed between the world’s pharmaceutical and biotechnology companies since 2012. Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology.
Intraocular Lens Market – Global Forecasts from 2018 to 2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Intraocular Lens Market – Forecasts From 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering. The Intraocular lens market is projected to grow at a CAGR of 5.98% to reach US$14.759 billion by 2023, from US$10.416 billion in 2017. Growing prevalence of eye diseases like cataracts and increase in initiatives taken by the government to eliminate avoidable blindness are expected to fuel the growth of the intraocular lens market. According to World
Ophthalmology Disease & Epidemiology Overview 2018 Featuring Alimera Sciences, Allergan, Regeneron, Bayer, Santen, Roche, Genentech, & Novartis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmology – Disease & Epidemiology Overview” report from Decision Resources Group has been added to ResearchAndMarkets.com’s offering. This report provides a disease market overview for each indication and global epidemiology overviews for each indication. The Ophthalmology Disease & Epidemiology Overview report provides disease market overviews and global epidemiology overviews for 4 indications in the Ophthalmology therapy area: Diabetic Macular Edema
Retinopathy of Prematurity – 2018 Pipeline Insight Featuring Biomar Microbial Technologies, F. Hoffmann-La Roche, Recordati, Radikal Therapeutics, EyeGene, and Insmed – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinopathy of Prematurity – Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Retinopathy of Prematurity development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by development